Skip to main content

Table 2 Plasma clinical chemistries

From: Different doses of supplemental vitamin D maintain interleukin-5 without altering skeletal muscle strength: a randomized, double-blind, placebo-controlled study in vitamin D sufficient adults

 

placebo

200 IU

4000 IU

PTH (pg/ml)

   

   Pre

36.1 (13.9)

36.1 (14.6)

31.4 (10.3)

   7-d

40.7 (16.5)

35.8 (16.4)

30.8 (11.4)

   14-d

38.5 (11.0)

31.7 (13.1)

30.3 (7.9)

   21-d

35.0 (13.5)

31.1 (11.0)

25.9 (8.3)

   28-d

35.5 (12.6)

33.0 (17.9)

32.1 (11.4)

calcium (mg/dl)

   

   Pre

9.22 (0.27)

9.36 (0.26)

9.32 (0.22)

   7-d

9.06 (0.16)

9.21 (0.38)

9.38 (0.26)

   14-d

9.15 (0.24)

9.22 (0.27)

9.41 (0.21)

   21-d

9.09 (0.31)

9.38 (0.29)

9.30 (0.28)

   28-d

9.16 (0.24)

9.39 (0.35)

9.35 (0.23)

creatinine (mg/dl)

   

   Pre

0.93 (0.08)

0.91 (0.14)

0.98 (0.17)

   7-d

0.92 (0.08)

0.97 (0.16)

0.98 (0.15)

   14-d

0.94 (0.09)

0.92 (0.13)

0.97 (0.17)

   21-d

0.92 (0.13)

0.92 (0.15)

0.98 (0.15)

   28-d

0.94 (0.16)

0.91 (0.15)

1.01 (0.13)

eGFR (ml/min/1.73 m2)

   

   Pre

90.9 (15.6)

91.9 (12.6)

87.7 (11.3)

   7-d

91.1 (12.3)

85.5 (15.0)

87.5 (10.2)

   14-d

89.1 (13.0)

89.7 (9.2)

89.5 (12.5)

   21-d

91.6 (8.0)

91.0 (13.2)

88.0 (12.5)

   28-d

90.2 (12.1)

92.1 (14.3)

84.7 (9.3)

  1. Data presented as mean (SD)
Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us